A comprehensive review and update on ulcerative colitis

M Gajendran, P Loganathan, G Jimenez, AP Catinella… - Disease-a-month, 2019 - Elsevier
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that
causes continuous mucosal inflammation extending from the rectum to the more proximal …

Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium

B Shen, GS Kochhar, DT Rubin, SV Kane… - The Lancet …, 2022 - thelancet.com
Pouchitis, Crohn's disease of the pouch, cuffitis, polyps, and extraintestinal manifestations of
inflammatory bowel disease are common inflammatory disorders of the ileal pouch. Acute …

AGA clinical practice guideline on the management of pouchitis and inflammatory pouch disorders

EL Barnes, M Agrawal, G Syal, AN Ananthakrishnan… - Gastroenterology, 2024 - Elsevier
Background & Aims Pouchitis is the most common complication after restorative
proctocolectomy with ileal pouch–anal anastomosis for ulcerative colitis. This American …

Ileal-anal pouches: a review of its history, indications, and complications

KS Ng, SJ Gonsalves, PM Sagar - World journal of …, 2019 - pmc.ncbi.nlm.nih.gov
The ileal pouch anal anastomosis (IPAA) has revolutionised the surgical management of
ulcerative colitis (UC) and familial adenomatous polyposis (FAP). Despite refinement in …

Current management of enterocutaneous fistula

AR Evenson, JE Fischer - Journal of Gastrointestinal Surgery, 2006 - Springer
Enterocutaneous fistulas, defined as abnormal communications between bowel and skin,
are among the most challenging conditions managed by the general surgeon. In an era …

Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis

MM Lawson, AG Thomas… - Cochrane Database of …, 2006 - cochranelibrary.com
Background Anti‐TNF‐α agents have been shown to be effective for the induction of
remission in Crohn's disease. The role of TNF‐α blocking agents in ulcerative colitis is …

Systematic review with meta-analysis: anti-TNF therapy in refractory pouchitis and Crohn's disease-like complications of the pouch after ileal pouch-anal anastomosis …

M Huguet, B Pereira, M Goutte… - Inflammatory bowel …, 2018 - academic.oup.com
Background Inflammatory complications including chronic refractory pouchitis and Crohn's
disease (CD)-like complications of the pouch are common complications after ileal pouch …

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel

MC Hochberg, MG Lebwohl, SE Plevy… - Seminars in arthritis and …, 2005 - Elsevier
OBJECTIVE: To review the benefits and risks associated with the use of the tumor necrosis
factor (TNF)-blockers in various indications (eg, rheumatoid arthritis [RA], Crohn's disease …

Management of pouchitis and other common complications of the pouch

RL Dalal, B Shen, DA Schwartz - Inflammatory Bowel Diseases, 2018 - academic.oup.com
Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) has become the
preferred surgical treatment for refractory or complicated ulcerative colitis (UC) and familial …

Efficacy of vedolizumab for refractory pouchitis of the ileo-anal pouch: results from a multicenter US cohort

M Gregory, KN Weaver, P Hoversten… - Inflammatory bowel …, 2019 - academic.oup.com
Abstract Background and Aims Inflammation of the pouch after ileal pouch-anal anastomosis
(IPAA) can significantly impact quality of life and be difficult to treat. We assessed the …